Skip to content
Search

Latest Stories

RPS England urges government to review decision on Covid-19 vaccine indemnity

The Royal Pharmaceutical Society (RPS) England has raised concern over the government's decision to discontinue state-backed indemnity for community pharmacists delivering Covid-19 vaccinations in England.

It has urged the government to review its decision so that the pharmacists can continue to support phase 3 of the Covid-19 vaccination programme. 


RPS England Chair Thorrun Govind in a letter to Nadhim Zahawi MP, minister for Covid vaccine deployment, has expressed concern that community pharmacists who are working in the national interest to support Phase 3 of the Covid-19 vaccination programme will be required to pay for indemnity insurance themselves from 31 August, which had previously been covered by a state-backed scheme.

RPS England Chair Thorrun Govind said: “Pharmacists across the country have been integral to making the Covid-19 vaccination programme a success, and have helped build the foundation for the country to return to a sense of freedom.

“Just as the government is looking to widen uptake of vaccinations, expecting community pharmacists to now start paying for indemnity insurance out of their own pocket is an extraordinary position.

“While some NHS workers have been offered a pay rise, the government is quietly expecting community pharmacists to pay more.

“The government must urgently review this injustice so that all pharmacists can help deliver this national ambition on Covid-19 vaccinations.”

More For You

Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less
Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less